255 related articles for article (PubMed ID: 22512997)
1. Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
Yorio JT; Yan J; Xie Y; Gerber DE
Clin Lung Cancer; 2012 Nov; 13(6):448-57. PubMed ID: 22512997
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
Berry MF; Canchola AJ; Gensheimer MF; Gomez SL; Cheng I
Clin Lung Cancer; 2018 Sep; 19(5):e745-e758. PubMed ID: 30149883
[TBL] [Abstract][Full Text] [Related]
3. Health care disparities among octogenarians and nonagenarians with stage III lung cancer.
Cassidy RJ; Zhang X; Switchenko JM; Patel PR; Shelton JW; Tian S; Nanda RH; Steuer CE; Pillai RN; Owonikoko TK; Ramalingam SS; Fernandez FG; Force SD; Gillespie TW; Curran WJ; Higgins KA
Cancer; 2018 Feb; 124(4):775-784. PubMed ID: 29315497
[TBL] [Abstract][Full Text] [Related]
4. Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative Intent.
Rice SR; Vyfhuis MAL; Scilla KA; Burrows WM; Bhooshan N; Suntharalingam M; Edelman MJ; Feliciano J; Badiyan SN; Simone CB; Bentzen SM; Feigenberg SJ; Mohindra P
Clin Lung Cancer; 2020 May; 21(3):e130-e141. PubMed ID: 31708388
[TBL] [Abstract][Full Text] [Related]
5. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer diagnostic and treatment intervals in the United States: a health care disparity?
Yorio JT; Xie Y; Yan J; Gerber DE
J Thorac Oncol; 2009 Nov; 4(11):1322-30. PubMed ID: 19752757
[TBL] [Abstract][Full Text] [Related]
7. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
[TBL] [Abstract][Full Text] [Related]
8. Race and sex differences in the receipt of timely and appropriate lung cancer treatment.
Shugarman LR; Mack K; Sorbero ME; Tian H; Jain AK; Ashwood JS; Asch SM
Med Care; 2009 Jul; 47(7):774-81. PubMed ID: 19536007
[TBL] [Abstract][Full Text] [Related]
9. Rurality, Stage-Stratified Use of Treatment Modalities, and Survival of Non-small Cell Lung Cancer.
Ray MA; Faris NR; Derrick A; Smeltzer MP; Osarogiagbon RU
Chest; 2020 Aug; 158(2):787-796. PubMed ID: 32387525
[TBL] [Abstract][Full Text] [Related]
10. Effect of insurance type on perioperative outcomes after robotic-assisted pulmonary lobectomy for lung cancer.
Deol PS; Sipko J; Kumar A; Tsalatsanis A; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
Surgery; 2019 Aug; 166(2):211-217. PubMed ID: 31202473
[TBL] [Abstract][Full Text] [Related]
11. Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
Farrow NE; An SJ; Speicher PJ; Harpole DH; D'Amico TA; Klapper JA; Hartwig MG; Tong BC
J Thorac Cardiovasc Surg; 2020 Jul; 160(1):261-271.e1. PubMed ID: 31924363
[TBL] [Abstract][Full Text] [Related]
12. Effect of insurance status on the surgical treatment of early-stage non-small cell lung cancer.
Groth SS; Al-Refaie WB; Zhong W; Vickers SM; Maddaus MA; D'Cunha J; Habermann EB
Ann Thorac Surg; 2013 Apr; 95(4):1221-6. PubMed ID: 23415239
[TBL] [Abstract][Full Text] [Related]
13. Disparities in Systemic Treatment Use in Advanced-stage Non-Small Cell Lung Cancer by Source of Health Insurance.
Maguire FB; Morris CR; Parikh-Patel A; Cress RD; Keegan THM; Li CS; Lin PS; Kizer KW
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1059-1066. PubMed ID: 30842132
[TBL] [Abstract][Full Text] [Related]
14. Persistence of racial disparities in early-stage lung cancer treatment.
Wolf A; Alpert N; Tran BV; Liu B; Flores R; Taioli E
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1670-1679.e4. PubMed ID: 30685165
[TBL] [Abstract][Full Text] [Related]
15. Does access to private healthcare influence potential lung cancer cure rates?
John TJ; Plekker D; Irusen EM; Koegelenberg CFN
S Afr Med J; 2017 Jul; 107(8):687-690. PubMed ID: 28809615
[TBL] [Abstract][Full Text] [Related]
16. Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid.
Bradley CJ; Dahman B; Given CW
J Clin Oncol; 2008 Nov; 26(31):5067-73. PubMed ID: 18794546
[TBL] [Abstract][Full Text] [Related]
17. Variations in Receipt of Curative-Intent Surgery for Early-Stage Non-Small Cell Lung Cancer (NSCLC) by State.
Sineshaw HM; Wu XC; Flanders WD; Osarogiagbon RU; Jemal A
J Thorac Oncol; 2016 Jun; 11(6):880-9. PubMed ID: 26980472
[TBL] [Abstract][Full Text] [Related]
18. Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients.
Shewale JB; Correa AM; Brown EL; Leon-Novelo LG; Nyitray AG; Antonoff MB; Hofstetter WL; Mehran RJ; Rice DC; Walsh GL; Roth J; Vaporciyan AA; Swisher SG; Sepesi B
Ann Thorac Surg; 2020 Feb; 109(2):404-411. PubMed ID: 31539514
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution.
Sher DJ; Liptay MJ; Fidler MJ
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):303-12. PubMed ID: 24685443
[TBL] [Abstract][Full Text] [Related]
20. Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer.
Duma N; Idossa DW; Durani U; Frank RD; Paludo J; Westin G; Lou Y; Mansfield AS; Adjei AA; Go RS; Ailawadhi S
Clin Lung Cancer; 2020 May; 21(3):e115-e129. PubMed ID: 31570228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
